AML-193(人外周血急性单核细胞白血病)
CBP61125
询 价
索取STR
产品描述
产品数据库
I. General information | |
Synonyms: | AML-193 |
Background: | This line was formerly designated ATCC HTB-188. |
Species: | Homo sapiens, human |
Tissue: | peripheral blood |
Disease: | acute monocytic leukemia |
Gender: | female, 13 years |
Morphology: | lymphoblast |
Growth Mode: | suspension |
Doubling Time: | N/A |
DNA Profile: | Amelogenin: X CSF1PO: 11,12 D13S317: 12 D16S539: 12 D5S818: 9,13 D7S820: 9,12 THO1: 7,9 TPOX: 8,9 vWA: 15,17 Cobioer’s Cell Line Authentication Service |
Culture Medium: |
IMDM+20%FBS + GM-CSF (10 ng/ml) or 10% vol conditioned medium of cell line 5637 AML-193完全培养基,# CBP61125M |
Cryopreservation medium: | 90%FBS+10%DMSO |
Antigen Expression: | CD15, human; Homo sapiens, expressed (75 to 95% of the cells) (75 to 95% of the cells) |
Receptor Expression: | N/A |
Oncogene: | N/A |
Genes Expressed: | CD15, human; Homo sapiens, expressed (75 to 95% of the cells) (75 to 95% of the cells) |
Cellular Products: | N/A |
Tumor Formation: | N/A |
Comments: | Interleukin-3 (interleukin 3, IL-3) and granulocyte/macrophage colony stimulating factor (GM-CSF) act synergistically to stimulate growth of the cells. Granulocyte colony stimulating factor (G-CSF) also supports short term and long term growth of AML-193 cells and acts synergistically with GM-CSF in inducing proliferation of the cells. For more information, please contact Cobioer (4008-750-250). |